Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | PSMB5 | P28074 | 15/20 | 0.39 |
| ▸ | PSMB1 | P20618 | 6/20 | 0.39 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.37 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | CASP7 | P55210 | 1/20 | 0.36 |
| ▸ | PSMB2 | P49721 | 2/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | CTSG | P08311 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CMA1 | P23946 | 1/20 | 0.35 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.35 |
| ▸ | PSMB10 | P40306 | 1/20 | 0.35 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.35 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25400333 | 1.00 | CCR1 (0.41) | CCR1RAB9APSMB5PSMB1PSMB8 | |
| SCHEMBL25399817 | 0.87 | CASP1 (0.43) | PSMB5PSMB1PSMB8CASP1CASP3 | |
| SCHEMBL25399824 | 0.87 | CASP1 (0.43) | PSMB5PSMB1PSMB8CASP1CASP3 | |
| SCHEMBL25398921 | 0.85 | CCR1 (0.42) | CCR1RAB9APSMB5PSMB1PSMB8 | |
| SCHEMBL25399414 | 0.85 | CCR1 (0.42) | CCR1PSMB5PSMB1PSMB8CASP1 | |
| SCHEMBL25399419 | 0.85 | CCR1 (0.42) | CCR1PSMB5PSMB1PSMB8CASP1 | |
| SCHEMBL25398919 | 0.85 | CCR1 (0.42) | CCR1RAB9APSMB5PSMB1PSMB8 | |
| SCHEMBL25400906 | 0.83 | PSMB5 (0.46) | PSMB5PSMB1PSMB8PSMB2ELANE | |
| SCHEMBL25400915 | 0.83 | PSMB5 (0.46) | PSMB5PSMB1PSMB8PSMB2ELANE | |
| SCHEMBL25399866 | 0.82 | CASP1 (0.43) | CCR1RAB9APSMB5PSMB1PSMB8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570675-B2 | Boronic acid compounds | LG CHEM, LTD. (KR) | 2026-03-10 | — | — | US | disclosed |
| US-20240101579-A1 | BORONIC ACID COMPOUNDS | LG CHEM, LTD. (KR) | 2024-03-28 | — | — | US | disclosed |
| EP-4242213-A1 | BORONIC ACID COMPOUND | Lg Chem, Ltd. (KR) | 2023-09-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570675-B2 | Boronic acid compounds | PSMB6, PSMB3, PSMB2 | CCR1 297/4885RAB9A 715/4885PSMB5 10/4885 |
| US-20240101579-A1 | BORONIC ACID COMPOUNDS | PSMB11, PSMB1, BACH1 | CCR1 2541/4885RAB9A 931/4885PSMB5 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.